The poultry vaccines market is projected to grow from USD 7.8 billion in 2026 to USD 19.2 billion by 2036, at a CAGR of 9.4%. Live attenuated vaccines will dominate with a 42.0% market share, while newcastle disease will lead the applications segment with a 28.0% share.